However, many SLC34A1 and SLC34A3 monoallelic carriers appear to have a lower TmP/GFR, elevated calcitriol levels, hypercalciuria, and a higher risk to develop kidney stones than the general population [61▪▪,62]. This evidence concerns the gene SLC34A3 and nephrolithiasis.